RESUMPTION OF TRADING FROM JULY 10, 2025

Paris (France), 10 July 2025

Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) informs its shareholders of the resumption of trading of its shares from the opening of the markets on July 10, 2025. Following the validation by Euronext, this resumption of trading follows the publication, on July 9, 2025, of its annual financial report for the financial year ending December 31, 2024.

For more information, visit www.valeriotx.com.

CONTACTS
Valerio Therapeutics
Investor Relations:
ir@valeriotx.com | +33 (0) 1 70 38 33 99